Products

What will AGI do for Abaperidone?

This classification denotes an antipsychotic agent with the molecular formula C25H25FN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40755Z8956, chemically known as 7-(3-(4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3-(hydroxymethyl)-4h-1-benzopyran-4-one but generally known as abaperidone, which bears US NIH Compound Identifier 3037308. Abaperidone most often appears in forms base and hydrochloride. European Medicines Agency schedules Abaperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00232MIG. The term ABAPERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule abaperidone under HS 29349990 and SITC 51579. As of Q4 2014, ABAPERIDONE remains the US FDA Preferred Term for this commodity. Abaperidone bears US NLM identifiers UMLS ID C0762225 and NCI Concept Code C73280. SMILES: FC1CC2ONC(C3CCN(CC3)CCCOC3CC4OCC(C(=O)C4CC3)CO)C2CC1.

How AGI delivers it

Four ways AGI delivers for Abaperidone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Abaperidone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Abaperidone, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Abaperidone connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Particle Size Distributionmodel